22nd Century enters agreement with Transo-Pharm for cannabinoid APIs

22nd Century and GVB Biopharma have entered into an agreement with Cannabinoid API Solutions and Transo-Pharm for global sales, marketing and distribution of GVB’s Cannabinoid APIs. The company said, "With more than 35 years of industry experience as a leading global supplier of pharmaceutical grade APIs, Transo-Pharm is a well-established supplier and distributor of pharmaceutical APIs to a broad portfolio of branded and generic finished drug product manufacturers, including more than 75 current active ongoing development programs. Transo-Pharm is partnered with an extensive range of reputable multinational pharmaceutical companies, all of which will have immediate access to GVB’s cannabinoid APIs."